Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 1983 May 21;286(6378):1607-9.
doi: 10.1136/bmj.286.6378.1607.

Advanced carcinoma of the prostate: treatment with a gonadotrophin releasing hormone agonist

J M Allen, J P O'Shea, K Mashiter, G Williams, S R Bloom

Advanced carcinoma of the prostate: treatment with a gonadotrophin releasing hormone agonist

J M Allen et al. Br Med J (Clin Res Ed). .

Abstract

Ten patients with advanced progressive adenocarcinoma of the prostate were treated with a long acting analogue of gonadotrophin releasing hormone. Eight of these patients responded to treatment in terms of pain relief and clinical regression of tumour. Serum gonadotrophin and testosterone concentrations were significantly suppressed by the end of the second week of treatment, testosterone concentrations being comparable with those achieved by castration. The two patients who failed to respond had both relapsed previously when receiving conventional treatment, and neither showed any endocrine response to the analogue. Superagonists of gonadotrophin releasing hormone may be the treatment of choice in adenocarcinoma of the prostate, but further trials are required to establish long term safety and efficacy.

PubMed Disclaimer

References

    1. J Clin Endocrinol Metab. 1972 Apr;34(4):671-5 - PubMed
    1. J Endocrinol. 1972 May;53(2):261-76 - PubMed
    1. J Endocrinol. 1973 Mar;56(3):431-9 - PubMed
    1. Steroids. 1975 Jun;25(6):753-62 - PubMed
    1. Acta Endocrinol (Copenh). 1979 May;91(1):1-13 - PubMed

LinkOut - more resources